GWS
LEGN icon

Glassman Wealth Services’s Legend Biotech LEGN Stock Holding History

Glassman Wealth Services’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-234
Closed -$14.1K – 1072
2023
Q4 		$14.1K Hold
234
– – ﹤0.01% 787
2023
Q3 		$15.7K Sell
234
-46
-16% -$3.19K ﹤0.01% 722
2023
Q2 		$19.3K Sell
280
-97
-26% -$6.34K ﹤0.01% 627
2023
Q1 		$18.2K Sell
377
-46
-11% -$2.25K ﹤0.01% 653
2022
Q4 		$21.1K Buy
423
+77
+22% +$3.73K ﹤0.01% 648
2022
Q3 		$14K Hold
346
– – ﹤0.01% 712
2022
Q2 		$19K Buy
346
+105
+44% +$4.43K ﹤0.01% 642
2022
Q1 		$9K Sell
241
-179
-43% -$7.07K ﹤0.01% 863
2021
Q4 		$20K Buy
+420
New +$21.3K ﹤0.01% 610

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Glassman Wealth Services's LEGN Position: Q1 2024 in Review

Glassman Wealth Services sold out of Legend Biotech (LEGN) in Q1 2024, closing a stake of 234 shares — an estimated $14.1K sold.

Glassman Wealth Services first reported a position in LEGN in Q4 2021 and held it in 9 quarters. The position peaked at $21.1K in Q4 2022. 192 funds tracked by Wall St. Rank hold LEGN as of Q1 2024.

  • Glassman Wealth Services reported no remaining Legend Biotech position as of Q1 2024 after selling out during the quarter.
  • Glassman Wealth Services sold 234 Legend Biotech shares in Q1 2024, an estimated $14.1K.
  • Glassman Wealth Services first reported a position in Legend Biotech in Q4 2021 and held it in 9 quarters.
  • Glassman Wealth Services's Legend Biotech position peaked at $21.1K in Q4 2022.
  • 192 funds tracked by Wall St. Rank held Legend Biotech as of Q1 2024.

Based on Glassman Wealth Services's 13F filing for Q1 2024, filed 3 May 2024.